Muscle Relaxant Drugs Market Size
Muscle Relaxant Drugs Market size was valued to be USD 4.1 billion in 2022 and is expected to reach USD 9.4 billion in 2032 with a CAGR of 6.4% from 2023 to 2032. The market's significant growth is primarily driven by the rising geriatric population coupled with growing prevalence of chronic pain along with lower back pain.

For instance, in 2022, according to World Health Organization (WHO), the lower back pain affected nearly 619 million people globally and it is estimated that the number of cases will increase to 843 million cases by 2050. Therefore, patient awareness towards pain management drugs for the musculoskeletal r disorders along with the surge in drug discovery & development is expected to propel the growth of the market.
Muscle relaxant drugs, also known as muscle relaxants, are a class of drugs that are used to reduce muscle tension, stiffness, and spasms. They work by affecting the central nervous system or the muscle itself to alleviate discomfort and improve mobility in conditions associated with muscle-related issues. They are prescribed for various conditions such as neck, & low back pain, myofascial pain syndrome and fibromyalgia among other conditions. In addition, they are also used during surgical interventions along with general aesthetics for muscle relaxation.
Muscle Relaxant Drugs Market Report Attributes
Report Attribute |
Details |
Base Year | 2022 |
---|
Muscle Relaxant Drugs Market Size in 2022 | USD 4.1 Billion |
---|
Forecast Period | 2023 to 2032 |
---|
Forecast Period 2023 to 2032 CAGR | 6.4% |
---|
2032 Value Projection | USD 9.4 Billion |
---|
Historical Data for | 2018 to 2022 |
---|
No. of Pages | 200 |
---|
Tables, Charts & Figures | 322 |
Segments covered | Drug Type, Dosage Form, Application, Route of Administration, Distribution Channel and Region |
---|
Growth Drivers | - Increasing geriatric population coupled with chronic diseases
- Increasing prevalence of musculoskeletal disorders
- Growing advancement in drug development
|
---|
Pitfalls & Challenges | - Side-effects associated with muscle relaxants
- Strict regulatory norms
|
---|
COVID-19 Impact
The COVID-19 pandemic brought a silver lining to the muscle relaxant drugs market. Stuck at home, people leaned into telemedicine and video consultations for medical advice. This opened the door to more awareness and education about muscle relaxant drugs, especially for those with muscle pain and discomfort. With an increased focus on self-care and managing stress, people became more interested in ways to unwind and ease muscle tension. This led to a surge in demand for muscle relaxant drugs, as folks sought relief from the physical strain of remote work, limited movement, and the general stress of the pandemic.
Muscle Relaxant Drugs Market Driving Factors
As the number of older people around the world keeps growing, so does the demand for muscle relaxants. That's because aging often brings with it aches and pains in the muscles and joints, like stiffness, spasms, and discomfort. In fact, research shows that a huge number of people worldwide suffer from these kinds of problems. But it's not just old age that can lead to muscle pain. Injuries from playing sports and chronic pain in younger people can also contribute to the need for muscle relaxants. And with advances in medicine, new treatments and technologies are being developed to help ease these pains. Government approvals and changes in how doctors treat muscle pain are also helping to drive the growth of the muscle relaxant market. This is all good news for people who are struggling with muscle pain and discomfort. With the right medication and treatment, they can find relief and live more active lives.
Muscle Relaxant Drugs Market Restraint
Muscle relaxers can be really helpful for certain muscle issues, but it's important to know about the potential side effects too. Some muscle relaxers can make you feel drowsy or less alert, and they can cause dry mouth which can be annoying and lead to other problems. Also, they can react with other medicines you're taking, which can be risky or make them less effective. Because of these side effects, doctors need to carefully weigh the pros and cons before prescribing muscle relaxers. They'll consider your medical history, any other medications you're taking, and the potential risks and benefits for you.
Muscle Relaxant Drugs Market Analysis

Imagine you're having a chat with a friend about different ways to relax sore muscles. "Hey, did you know there are different types of muscle relaxers?" you say. "There's stuff for your whole body, like skeletal muscle relaxers, nerve blockers, and even stuff just for your face." "Wow, I never knew that," your friend replies. "The ones for your skeleton muscles are the most popular," you tell them. "They work great for cramps, spasms, and any other time your muscles are being stubborn. They chill them out, so they don't tense up and hurt." "That's awesome," your friend says. "I've had some really bad back spasms before. Those would have come in handy." "Exactly," you say. "And they're not just for everyday aches and pains. Even if you're recovering from surgery, they can help keep your muscles from getting all stiff and sore." "That's something I'll definitely keep in mind," your friend says. "So, the next time your muscles are giving you a hard time, don't just suffer. There are options to help you relax and feel better."

Hey, did you know that muscle relaxant medicines come in different forms like pills, capsules, liquids, gels, creams, and sprays? Among these, pills were the most popular choice last year, bringing in a whopping 2 billion dollars worldwide. Why pills? Well, they've got a few perks. Doctors love 'em because they can control the dosage precisely, so they can give you the exact amount you need. And bonus, pills have a longer shelf life than other forms, so they'll still be good when you need them.
If you're struggling with painful muscle spasms, you'll be glad to know there are a variety of medications available to help. In fact, the market for these drugs is growing rapidly, and is expected to reach $4 billion by 2032. That's because these drugs can provide significant relief from muscle spasms and pain. They're often used as part of a treatment plan that includes physical therapy, exercise, and lifestyle changes. By working together, these treatments can help you get your pain under control and improve your quality of life.
When it comes to muscle relaxants, you've got three main ways to take themby mouth (oral), through a needle or IV (parenteral), and on your skin (topical). Most people prefer taking their muscle relaxants by mouth. That's because they're used to popping pills, and it's super easy to do. This makes them more likely to stick to their treatment plan, which is important for getting better. Plus, you don't need any special training to swallow a pill. You just do it yourself, no problem.
When it comes to buying muscle relaxants, there are three main optionshospital pharmacies, specialized or retail pharmacies, and online pharmacies. Hospitals have been the top sellers of muscle relaxants, bringing in $2.3 billion in 2022 alone. This is because hospitals play a huge role in distributing, managing, and giving out these medications to patients. Inside the hospital, muscle relaxants are used for all sorts of things, like easing muscle pain and spasms, helping with surgeries, and keeping critically ill patients comfortable. Plus, doctors and nurses work closely with hospital pharmacies to make sure each patient gets the right muscle relaxant for their condition and treatment plan.

Muscle relaxant drugs are in high demand in North America, with over a third of the global market in 2022. This is largely due to the growing number of people suffering from muscle-related issues like stiffness, spasms, and pain. Factors such as our aging population, lack of exercise, and stressful jobs are contributing to this trend. As a result, people are looking for effective muscle relaxants to relieve their pain. North America is a leader in healthcare, prioritizing patient well-being and access to advanced treatments like muscle relaxants. The focus on patient-centered care and the convenience of telemedicine are making it easier for people to get the care and prescriptions they need. This has further fueled the demand for muscle relaxants in the region.
Muscle relaxant drugs Market Share
The prominent players in the muscle relaxant drugs market are
- Amneal Pharmaceuticals LLC
- Ipsen Biopharmaceuticals, Inc
- Merz Pharmaceuticals, LLC
- Mylan (Viatris)
- Sanofi
- Pfizer Inc
- Novartis AG
- eva Pharmaceuticals Industries Ltd, Inc
- Vertical Pharmaceuticals
- Sun Pharmaceutical Industries Ltd
- SteriMax Inc
- Par Pharmaceutical
- Abbott Laboratories
- F. Hoffmann-La Roche AG
These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.
Muscle relaxant drugs Industry News
- In June 2022, Amneal Pharmaceuticals launched LYVISPAH, a baclofen oral granules specialty product approved by the U.S. FDA for treating spasticity associated to multiple sclerosis and other spinal cord disorders. This helped the company in expanding its product portfolio and generate maximum revenue from its sales.
- In January 2022, Amneal Pharmaceuticals purchased Saol's Baclofen franchise, containing Lioresal and LYVISPAH, and a pipeline product under development. The acquisition enlarged the company's commercial institutional and specialty portfolio in neuromuscular segment and helped in the growth of the market.
The muscle relaxant drugs market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Drug Type
- Skeletal muscle relaxant drugs
- Neuromuscular blocking agents
- Facial muscle relaxant drugs
By Dosage Form
- Tablet
- Capsule
- Liquid
- Gel, ointments & sprays
By Application
- Muscle spasm & pain relief
- Musculoskeletal disorders
- Surgery
- Other applications
By Route of Administration
By Distribution Channel
- Hospital pharmacy
- Specialty & retail pharmacy
- Online pharmacy
The above information is provided for the following regions and countries
- North America
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa